Drug Type Small molecule drug |
Synonyms Evodenoson (USAN), ATL-313, DE-112 |
Target |
Action agonists |
Mechanism A2aR agonists(Adenosine A2a receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29N7O6 |
InChIKeySQJXTUJMBYVDBB-RQXXJAGISA-N |
CAS Registry844873-47-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 2 | United States | 01 Jan 2011 | |
Glaucoma | Phase 2 | - | - | |
Glaucoma | Phase 2 | - | - | |
Hematologic Neoplasms | Preclinical | United States | - | |
Multiple Sclerosis | Preclinical | United States | - | |
Neuralgia | Preclinical | United States | - |